Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Hematology

Recognizing Symptoms and Warning Signs

At a Glance

Cold agglutinin disease commonly causes fatigue, blue or purple fingers and toes in the cold, and shortness of breath from a low red blood cell count. Sudden yellow skin, dark urine, severe weakness, chest pain, or stroke signs need urgent or emergency care.

Living with Cold Agglutinin Disease (CAD) involves managing a balance between chronic daily symptoms and the risk of sudden “flares” or exacerbations. Because your immune system reacts to the cold and to internal triggers like inflammation, your symptoms can change based on the weather, your health, and even your activity levels.

Chronic Daily Symptoms

Most people with CAD experience a baseline of symptoms that persist even when they are not in a crisis. These symptoms are primarily caused by anemia (low red blood cell count) and poor circulation in small blood vessels [1][2].

  • Profound Fatigue: Over 90% of patients report significant tiredness [3]. This is not ordinary sleepiness; it is a deep exhaustion caused by your body constantly working to replace destroyed red blood cells [4].
  • Acrocyanosis: When exposed to cold, your fingers, toes, nose, or ears may turn blue or purple [1]. This happens because the “cold” antibodies cause red blood cells to clump together (agglutination), temporarily blocking small blood vessels. Unlike Raynaud’s phenomenon, this usually does not involve a “white” phase and is generally not as painful, though it can be uncomfortable [1].
  • Shortness of Breath: You may feel winded during light exertion, such as climbing stairs, because your blood is carrying less oxygen [1][2].

Understanding the Hemolytic Crisis

An acute hemolytic crisis is a sudden, rapid increase in the destruction of red blood cells. These crises are often triggered by infection (such as the flu or pneumonia) or inflammation (such as from surgery or injury), which “supercharges” the immune system’s complement response [5][6].

During a crisis, you may notice:

  • Jaundice: A yellowing of the skin or the whites of the eyes caused by a buildup of bilirubin, a byproduct of broken-down red blood cells [2][7].
  • Dark Urine: Your urine may turn the color of tea or cola. This is a sign of intravascular hemolysis, meaning red blood cells are breaking apart directly inside your bloodstream [7][8].
  • Rapid Weakness: A sudden, severe drop in energy or feeling faint [9].

The Risk of Blood Clots

Research shows that people with CAD have a significantly higher risk of thromboembolic events (blood clots) than the general population [10]. One large study found that CAD patients are nearly twice as likely to experience a blood clot [10].

The risk is not limited to the winter; it remains elevated year-round [11]. These clots can be venous (such as a Deep Vein Thrombosis or DVT in the leg) or arterial (such as a heart attack or stroke) [12]. This increased risk makes it vital to recognize the early warning signs of a clot, such as sudden leg swelling or chest pain.

When to Seek Medical Care

Because CAD can change quickly, it is important to know when a symptom is an inconvenience and when it is an emergency.

Urgency Level Symptoms or Indicators Action to Take
Emergency (Call 911 or go to ER) Sudden chest pain, severe shortness of breath, confusion, fainting, or signs of a stroke (one-sided weakness, facial drooping). These could be signs of a Pulmonary Embolism (PE) or stroke. Seek immediate emergency medical intervention.
Urgent (Same-Day Contact) Sudden, painful swelling in one leg (possible DVT). Dark/tea-colored urine, new or worsening jaundice, a rapid drop in your ability to perform daily tasks, or a fever. Contact your hematologist or primary doctor immediately for blood tests (hemoglobin, LDH) or evaluation.
Next Visit Mildly increased fatigue, more frequent blue fingers/toes in the cold, or persistent but stable anemia symptoms. Discuss these changes at your next scheduled appointment or via the patient portal.

Important Note for Emergency Care: If you require a blood transfusion in an emergency, your medical team should ideally use an approved in-line blood warmer [1][13]. Infusing cold blood into a patient with CAD can worsen the destruction of red blood cells [13]. However, urgent transfusion decisions must be made by the treating transfusion service; never delay or refuse life-saving emergency care while trying to arrange equipment [1]. Inform the staff, and trust them to manage the crisis.

Safety Note for Complement Inhibitors: If you are on a complement inhibitor like sutimlimab, a fever, severe headache, stiff neck, rash, or confusion can be signs of meningitis or serious infection and merit prompt emergency medical advice.

Common questions in this guide

What symptoms are common with cold agglutinin disease?
Common daily symptoms include profound fatigue, shortness of breath with activity, and fingers, toes, nose, or ears that turn blue or purple in the cold. These symptoms are often related to anemia and reduced blood flow in small blood vessels.
How do I recognize a cold agglutinin disease hemolytic crisis?
A crisis may cause a sudden increase in weakness, yellowing of the skin or eyes, or tea- or cola-colored urine. Infection, inflammation, surgery, or injury can trigger rapid red blood cell breakdown, so these changes warrant same-day medical evaluation.
When should I call 911 for cold agglutinin disease symptoms?
Call 911 or go to an emergency department for sudden chest pain, severe shortness of breath, confusion, fainting, or signs of a stroke such as one-sided weakness or facial drooping. These symptoms can indicate a life-threatening blood clot or another medical emergency.
How can I tell if cold agglutinin disease may be causing a blood clot?
New painful swelling, redness, or pain in one leg can be a sign of a clot in a deep vein. Chest pain or sudden breathing trouble may signal a clot in the lungs, while one-sided weakness or facial drooping may signal a stroke; seek emergency care for these symptoms.
What should the emergency department know if I need a transfusion with CAD?
Tell the emergency and blood-bank teams that you have cold agglutinin disease. An in-line blood warmer is ideally used for a transfusion when appropriate, but do not delay or refuse life-saving treatment while equipment is being arranged; the treating transfusion service makes the decision.
What warning signs matter if I take sutimlimab?
If you take sutimlimab, fever, severe headache, stiff neck, rash, or confusion may signal meningitis or another serious infection. Seek prompt emergency medical advice rather than waiting for the symptoms to pass.
Why do some cold agglutinin disease blood samples need to stay warm?
Some cold agglutinin disease blood tests need samples kept at body temperature, about 37°C, because cold-sensitive antibodies can affect the results. Tell laboratory and emergency staff about your condition so they can follow the appropriate sample-handling instructions.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Cold agglutinin disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are my 'baseline' hemoglobin and LDH levels, and at what specific threshold should I call your office or go to the ER?
  2. 2.Given my specific risk factors, what is your recommendation for blood clot prevention?
  3. 3.How should I notify the laboratory or ER that my CAD-specific blood samples must be kept at body temperature (37°C) to ensure accuracy?
  4. 4.If I develop an infection like a cold or the flu, should I proactively increase my monitoring or change my treatment temporarily?
  5. 5.Do we have an emergency plan in place with the local hospital's blood bank in case I need an urgent transfusion?

References

References (13)
  1. 1

    Cold agglutinin disease: pathophysiology, diagnosis, and the evolving therapeutic landscape.

    Choi DH

    Blood research 2026; (61(1)).

    PMID: 42696222
  2. 2

    Refractory cold autoimmune hemolytic anemia as initial presentation of gastric B cell lymphoma: a case report.

    Fernando G, Samarasingha SAPN, Karunatilake H, et al.

    Journal of medical case reports 2025; (19(1)):487 doi:10.1186/s13256-025-05519-1.

    PMID: 41063194
  3. 3

    Development of the Cold Agglutinin Disease Symptoms and Impact Questionnaire (CAD-SIQ).

    Joly F, DasMahapatra P, DiBenedetti DB, et al.

    European journal of haematology 2023; (111(2)):211-219 doi:10.1111/ejh.13984.

    PMID: 37128840
  4. 4

    The Burden of Cold Agglutinin Disease on Patients' Daily Life: Web-Based Cross-sectional Survey of 50 American Patients.

    Joly F, Schmitt LA, Watson PAM, et al.

    JMIR formative research 2022; (6(7)):e34248 doi:10.2196/34248.

    PMID: 35867390
  5. 5

    New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

    Berentsen S

    Frontiers in immunology 2020; (11()):590 doi:10.3389/fimmu.2020.00590.

    PMID: 32318071
  6. 6

    Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.

    Fattizzo B, Pasquale R, Bellani V, et al.

    Frontiers in immunology 2021; (12()):791429 doi:10.3389/fimmu.2021.791429.

    PMID: 34899761
  7. 7

    Exacerbation of Secondary Cold Agglutinin Syndrome in the Setting of SARS-CoV-2.

    Bhagat YV, Hussien S, Queenan H, Michael MB

    Cureus 2021; (13(11)):e19387 doi:10.7759/cureus.19387.

    PMID: 34925989
  8. 8

    Cold Agglutinin Syndrome as the Initial Presentation of Acute Myeloid Leukemia: A Case Report.

    Sadeghi MV, Vosough Z, Jahansouz D

    Clinical case reports 2025; (13(10)):e71061 doi:10.1002/ccr3.71061.

    PMID: 41036160
  9. 9

    Cold agglutinin-induced hemolytic anemia during room temperature fluid resuscitation: a case report.

    Kawai Y, Deguchi M, Mizouchi N, et al.

    Journal of medical case reports 2021; (15(1)):169 doi:10.1186/s13256-021-02784-8.

    PMID: 33858500
  10. 10

    Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis.

    Broome CM, Cunningham JM, Mullins M, et al.

    Research and practice in thrombosis and haemostasis 2020; (4(4)):628-635 doi:10.1002/rth2.12333.

    PMID: 32548562
  11. 11

    Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.

    Röth A, Fryzek J, Jiang X, et al.

    Transfusion 2022; (62(1)):51-59 doi:10.1111/trf.16745.

    PMID: 34813663
  12. 12

    Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.

    Kamesaki T, Nishimura JI, Wada H, et al.

    International journal of hematology 2020; (112(3)):307-315 doi:10.1007/s12185-020-02899-6.

    PMID: 32608010
  13. 13

    A Rare Case of Severe Hemolytic Anemia and Pulmonary Embolism Secondary to Mycoplasma pneumoniae Infection.

    Kumaravel Kanagavelu AS, Nagumantry SK, Sagi SV, Oyibo SO

    Journal of medical cases 2022; (13(3)):119-124 doi:10.14740/jmc3866.

    PMID: 35356396

This page is for informational purposes about cold agglutinin disease symptoms and warning signs and does not replace professional medical advice. Contact your hematologist or emergency services for severe or rapidly worsening symptoms.